These findings demonstrate a variable expression of pIgR in pancreatic and periampullary adenocarcinoma, with low versus high expression being significantly associated with several adverse tumour characteristics, progressive disease and a shorter time to recurrence and death within five years. Here, PIGR is linked to neoplasm.